Latest filing published 29 Jun 2026 for ANAPTYSBIO, INC., €526k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Dennis Mulroy is a declared insider of Anaptysbio, Inc, with filings sourced from SEC (Form 4). We count 14 filings; the first trade dates from 2 June 2026 and the latest from 29 June 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The newest entry dates from 29 June 2026: a transaction of €526k, in Anaptysbio, Inc. Half of the filings or more reach the SEC (Form 4) feed on the day of the trade. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
14 of 14 declarations